Cargando…

Dysregulation of the Intestinal Microbiome in Patients With Haploinsufficiency of A20

INTRODUCTION: Haploinsufficiency of A20 (HA20) is a form of inborn errors of immunity (IEI). IEIs are genetically occurring diseases, some of which cause intestinal dysbiosis. Due to the dysregulation of regulatory T cells (Tregs) observed in patients with HA20, gut dysbiosis was associated with Tre...

Descripción completa

Detalles Bibliográficos
Autores principales: Toyofuku, Etsushi, Takeshita, Kozue, Ohnishi, Hidenori, Kiridoshi, Yuko, Masuoka, Hiroaki, Kadowaki, Tomonori, Nishikomori, Ryuta, Nishimura, Kenichi, Kobayashi, Chie, Ebato, Takasuke, Shigemura, Tomonari, Inoue, Yuzaburo, Suda, Wataru, Hattori, Masahira, Morio, Tomohiro, Honda, Kenya, Kanegane, Hirokazu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8834539/
https://www.ncbi.nlm.nih.gov/pubmed/35155270
http://dx.doi.org/10.3389/fcimb.2021.787667
_version_ 1784649212108996608
author Toyofuku, Etsushi
Takeshita, Kozue
Ohnishi, Hidenori
Kiridoshi, Yuko
Masuoka, Hiroaki
Kadowaki, Tomonori
Nishikomori, Ryuta
Nishimura, Kenichi
Kobayashi, Chie
Ebato, Takasuke
Shigemura, Tomonari
Inoue, Yuzaburo
Suda, Wataru
Hattori, Masahira
Morio, Tomohiro
Honda, Kenya
Kanegane, Hirokazu
author_facet Toyofuku, Etsushi
Takeshita, Kozue
Ohnishi, Hidenori
Kiridoshi, Yuko
Masuoka, Hiroaki
Kadowaki, Tomonori
Nishikomori, Ryuta
Nishimura, Kenichi
Kobayashi, Chie
Ebato, Takasuke
Shigemura, Tomonari
Inoue, Yuzaburo
Suda, Wataru
Hattori, Masahira
Morio, Tomohiro
Honda, Kenya
Kanegane, Hirokazu
author_sort Toyofuku, Etsushi
collection PubMed
description INTRODUCTION: Haploinsufficiency of A20 (HA20) is a form of inborn errors of immunity (IEI). IEIs are genetically occurring diseases, some of which cause intestinal dysbiosis. Due to the dysregulation of regulatory T cells (Tregs) observed in patients with HA20, gut dysbiosis was associated with Tregs in intestinal lamina propria. METHODS: Stool samples were obtained from 16 patients with HA20 and 15 of their family members. Infant samples and/or samples with recent antibiotics use were excluded; hence, 26 samples from 13 patients and 13 family members were analyzed. The 16S sequencing process was conducted to assess the microbial composition of samples. Combined with clinical information, the relationship between the microbiome and the disease activity was statistically analyzed. RESULTS: The composition of gut microbiota in patients with HA20 was disturbed compared with that in healthy family members. Age, disease severity, and use of immunosuppressants corresponded to dysbiosis. However, other explanatory factors, such as abdominal symptoms and probiotic treatment, were not associated. The overall composition at the phylum level was stable, but some genera were significantly increased or decreased. Furthermore, among the seven operational taxonomic units (OTUs) that increased, two OTUs, Streptococcus mutans and Lactobacillus salivarius, considerably increased in patients with autoantibodies than those without autoantibodies. DISCUSSION: Detailed interaction on intestinal epithelium remains unknown; the relationship between the disease and stool composition change helps us understand the mechanism of an immunological reaction to microorganisms.
format Online
Article
Text
id pubmed-8834539
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-88345392022-02-12 Dysregulation of the Intestinal Microbiome in Patients With Haploinsufficiency of A20 Toyofuku, Etsushi Takeshita, Kozue Ohnishi, Hidenori Kiridoshi, Yuko Masuoka, Hiroaki Kadowaki, Tomonori Nishikomori, Ryuta Nishimura, Kenichi Kobayashi, Chie Ebato, Takasuke Shigemura, Tomonari Inoue, Yuzaburo Suda, Wataru Hattori, Masahira Morio, Tomohiro Honda, Kenya Kanegane, Hirokazu Front Cell Infect Microbiol Cellular and Infection Microbiology INTRODUCTION: Haploinsufficiency of A20 (HA20) is a form of inborn errors of immunity (IEI). IEIs are genetically occurring diseases, some of which cause intestinal dysbiosis. Due to the dysregulation of regulatory T cells (Tregs) observed in patients with HA20, gut dysbiosis was associated with Tregs in intestinal lamina propria. METHODS: Stool samples were obtained from 16 patients with HA20 and 15 of their family members. Infant samples and/or samples with recent antibiotics use were excluded; hence, 26 samples from 13 patients and 13 family members were analyzed. The 16S sequencing process was conducted to assess the microbial composition of samples. Combined with clinical information, the relationship between the microbiome and the disease activity was statistically analyzed. RESULTS: The composition of gut microbiota in patients with HA20 was disturbed compared with that in healthy family members. Age, disease severity, and use of immunosuppressants corresponded to dysbiosis. However, other explanatory factors, such as abdominal symptoms and probiotic treatment, were not associated. The overall composition at the phylum level was stable, but some genera were significantly increased or decreased. Furthermore, among the seven operational taxonomic units (OTUs) that increased, two OTUs, Streptococcus mutans and Lactobacillus salivarius, considerably increased in patients with autoantibodies than those without autoantibodies. DISCUSSION: Detailed interaction on intestinal epithelium remains unknown; the relationship between the disease and stool composition change helps us understand the mechanism of an immunological reaction to microorganisms. Frontiers Media S.A. 2022-01-28 /pmc/articles/PMC8834539/ /pubmed/35155270 http://dx.doi.org/10.3389/fcimb.2021.787667 Text en Copyright © 2022 Toyofuku, Takeshita, Ohnishi, Kiridoshi, Masuoka, Kadowaki, Nishikomori, Nishimura, Kobayashi, Ebato, Shigemura, Inoue, Suda, Hattori, Morio, Honda and Kanegane https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Cellular and Infection Microbiology
Toyofuku, Etsushi
Takeshita, Kozue
Ohnishi, Hidenori
Kiridoshi, Yuko
Masuoka, Hiroaki
Kadowaki, Tomonori
Nishikomori, Ryuta
Nishimura, Kenichi
Kobayashi, Chie
Ebato, Takasuke
Shigemura, Tomonari
Inoue, Yuzaburo
Suda, Wataru
Hattori, Masahira
Morio, Tomohiro
Honda, Kenya
Kanegane, Hirokazu
Dysregulation of the Intestinal Microbiome in Patients With Haploinsufficiency of A20
title Dysregulation of the Intestinal Microbiome in Patients With Haploinsufficiency of A20
title_full Dysregulation of the Intestinal Microbiome in Patients With Haploinsufficiency of A20
title_fullStr Dysregulation of the Intestinal Microbiome in Patients With Haploinsufficiency of A20
title_full_unstemmed Dysregulation of the Intestinal Microbiome in Patients With Haploinsufficiency of A20
title_short Dysregulation of the Intestinal Microbiome in Patients With Haploinsufficiency of A20
title_sort dysregulation of the intestinal microbiome in patients with haploinsufficiency of a20
topic Cellular and Infection Microbiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8834539/
https://www.ncbi.nlm.nih.gov/pubmed/35155270
http://dx.doi.org/10.3389/fcimb.2021.787667
work_keys_str_mv AT toyofukuetsushi dysregulationoftheintestinalmicrobiomeinpatientswithhaploinsufficiencyofa20
AT takeshitakozue dysregulationoftheintestinalmicrobiomeinpatientswithhaploinsufficiencyofa20
AT ohnishihidenori dysregulationoftheintestinalmicrobiomeinpatientswithhaploinsufficiencyofa20
AT kiridoshiyuko dysregulationoftheintestinalmicrobiomeinpatientswithhaploinsufficiencyofa20
AT masuokahiroaki dysregulationoftheintestinalmicrobiomeinpatientswithhaploinsufficiencyofa20
AT kadowakitomonori dysregulationoftheintestinalmicrobiomeinpatientswithhaploinsufficiencyofa20
AT nishikomoriryuta dysregulationoftheintestinalmicrobiomeinpatientswithhaploinsufficiencyofa20
AT nishimurakenichi dysregulationoftheintestinalmicrobiomeinpatientswithhaploinsufficiencyofa20
AT kobayashichie dysregulationoftheintestinalmicrobiomeinpatientswithhaploinsufficiencyofa20
AT ebatotakasuke dysregulationoftheintestinalmicrobiomeinpatientswithhaploinsufficiencyofa20
AT shigemuratomonari dysregulationoftheintestinalmicrobiomeinpatientswithhaploinsufficiencyofa20
AT inoueyuzaburo dysregulationoftheintestinalmicrobiomeinpatientswithhaploinsufficiencyofa20
AT sudawataru dysregulationoftheintestinalmicrobiomeinpatientswithhaploinsufficiencyofa20
AT hattorimasahira dysregulationoftheintestinalmicrobiomeinpatientswithhaploinsufficiencyofa20
AT moriotomohiro dysregulationoftheintestinalmicrobiomeinpatientswithhaploinsufficiencyofa20
AT hondakenya dysregulationoftheintestinalmicrobiomeinpatientswithhaploinsufficiencyofa20
AT kaneganehirokazu dysregulationoftheintestinalmicrobiomeinpatientswithhaploinsufficiencyofa20